Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
Sign Up
Log in
L

Life Science REIT PLC
LSE:LABS

Watchlist Manager
Life Science REIT PLC
LSE:LABS
Watchlist
Price: 38.8 GBX 0.52% Market Closed
Market Cap: £135.8m
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

LABS Price Targets Summary
Life Science REIT PLC

Wall Street analysts forecast LABS stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LABS is 37.74 GBX with a low forecast of 37.37 GBX and a high forecast of 38.85 GBX.

LABS Lowest Forecast
Wall Street Target
37.37 GBX
-4% Downside
LABS Average Forecast
Wall Street Target
37.74 GBX
-3% Downside
LABS Highest Forecast
Wall Street Target
38.85 GBX
0% Upside
Lowest
Price Target
37.37 GBX
4% Downside
Average
Price Target
37.74 GBX
3% Downside
Highest
Price Target
38.85 GBX
0% Upside
Life Science REIT PLC Competitors:
Price Targets
WELL
Welltower Inc
20% Upside
DK
Delek US Holdings Inc
-7% Downside
CHCT
Community Healthcare Trust Inc
22% Upside
UHT
Universal Health Realty Income Trust
10% Upside
WELL
Welltower Inc
20% Upside
DK
Delek US Holdings Inc
-7% Downside
CHCT
Community Healthcare Trust Inc
22% Upside
UHT
Universal Health Realty Income Trust
10% Upside
UE
Urban Edge Properties
13% Upside
WERN
Werner Enterprises Inc
25% Upside
EFX
Equifax Inc
40% Upside

Revenue
Forecast

14% / Year
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
13%
Average Beat
14% / Year
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
13%
Average Beat

For the last 2 years the compound annual growth rate for Life Science REIT PLC's revenue is 14%. The projected CAGR for the next 2 years is 19%.

What are analyst estimates?

Operating Income
Forecast

48% / Year
Past Growth
35% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
48% / Year
Past Growth
35% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 2 years the compound annual growth rate for Life Science REIT PLC's operating income is 48%. The projected CAGR for the next 2 years is 35%.

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

What are analyst estimates?

See Also

Summary
LABS intrinsic value, competitors valuation, and company profile.
DCF Valuation
LABS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
LABS stock valuation using valuation multiples.
Wall Street Estimates
LABS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
LABS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is LABS's stock price target?
Price Target
37.74 GBX

According to Wall Street analysts, the average 1-year price target for LABS is 37.74 GBX with a low forecast of 37.37 GBX and a high forecast of 38.85 GBX.

What is Life Science REIT PLC's Revenue forecast?
Projected CAGR
19%

For the last 2 years the compound annual growth rate for Life Science REIT PLC's revenue is 14%. The projected CAGR for the next 2 years is 19%.

What is Life Science REIT PLC's Operating Income forecast?
Projected CAGR
35%

For the last 2 years the compound annual growth rate for Life Science REIT PLC's operating income is 48%. The projected CAGR for the next 2 years is 35%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 326,900+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett